MONITORING HEPARIN AND HIRUDIN THERAPIES BY ACTIVATED PARTIAL THROMBOPLASTIN TIME WITH A BED SIDE MONITOR AS WELL AS OTHER APPARATUS AND REAGENTS

被引：0
|
作者：
NURMOHAMED, MT [1 ]
STURK, A [1 ]
BERCKMANS, RJ [1 ]
BERENDS, F [1 ]
RIJNIERSE, JJMM [1 ]
TENCATE, JW [1 ]
BULLER, HR [1 ]
机构：
[1] UNIV AMSTERDAM,ACAD MED CTR,CTR HEMOSTASIS THROMBOSIS ATHEROSCLEROSIS & INFLAMMAT RES,1105 AZ AMSTERDAM,NETHERLANDS
来源：
THROMBOSIS AND HAEMOSTASIS | 1993年 / 69卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：865 / 865
页数：1
相关论文
共 50 条
  • [41] USE OF THE ACTIVATED PARTIAL THROMBOPLASTIN TIME FOR MONITORING HEPARIN-THERAPY - PROBLEMS AND POSSIBLE SOLUTIONS
    POLLER, L
    THOMSON, JM
    TABERNER, DA
    [J]. RESEARCH IN CLINIC AND LABORATORY, 1989, 19 (04): : 363 - 370
  • [42] ANTI-FACTOR XA VERSUS ACTIVATED PARTIAL THROMBOPLASTIN TIME FOR HEPARIN INFUSION MONITORING
    Jung, Sul
    Choi, Austin
    Lepore, Mark
    [J]. CRITICAL CARE MEDICINE, 2020, 48
  • [43] MONITORING HEPARIN-THERAPY - RELATIONSHIPS BETWEEN THE ACTIVATED PARTIAL THROMBOPLASTIN TIME AND HEPARIN ASSAYS BASED ON EXVIVO HEPARIN SAMPLES
    VANDENBESSELAAR, AMHP
    MEEUWISSEBRAUN, J
    BERTINA, RM
    [J]. THROMBOSIS AND HAEMOSTASIS, 1990, 63 (01) : 16 - 23
  • [44] Activated Partial Thromboplastin Time Versus Antifactor Xa Heparin Assay in Monitoring Unfractionated Heparin by Continuous Intravenous Infusion
    Guervil, David J.
    Rosenberg, Amy F.
    Winterstein, Almut G.
    Harris, Neil S.
    Johns, Thomas E.
    Zumberg, Marc S.
    [J]. ANNALS OF PHARMACOTHERAPY, 2011, 45 (7-8) : 861 - 868
  • [45] MONITORING ANTICOAGULANT-THERAPY BY ACTIVATED PARTIAL THROMBOPLASTIN TIME - HIRUDIN ASSESSMENT - AN EVALUATION OF NATIVE BLOOD AND PLASMA ASSAYS
    NURMOHAMED, MT
    BERCKMANS, RJ
    MORRIENSALOMONS, WM
    BERENDS, F
    HOMMES, DW
    RIJNIERSE, JJMM
    STURK, A
    [J]. THROMBOSIS AND HAEMOSTASIS, 1994, 72 (05) : 685 - 692
  • [46] STANDARDIZATION OF THE ACTIVATED PARTIAL THROMBOPLASTIN TIME FOR MONITORING OF HEPARIN-THERAPY - WHERE SHOULD WE GO
    VANDENBESSELAAR, AMHP
    [J]. RESEARCH IN CLINIC AND LABORATORY, 1989, 19 (04): : 371 - 377
  • [47] Comparison of Anti-Xa and Activated Partial Thromboplastin Time Monitoring for Heparin Dosing in Patients With Cirrhosis
    Fuentes, Amaris
    Gordon-Burroughs, Sherilyn
    Hall, Jeffrey B.
    Putney, David R.
    Monsour, Howard P., Jr.
    [J]. THERAPEUTIC DRUG MONITORING, 2015, 37 (01) : 40 - 44
  • [48] ACTIVATED PARTIAL THROMBOPLASTIN TIME AFTER HEPARIN REMOVAL (APTT/HR) IN A NEW SCHEME OF ANTICOAGULANT MONITORING
    BRANSON, HE
    GUPTA, N
    SLATER, LM
    FAGIN, A
    ARMENTROUT, SA
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1982, 12 (04) : 411 - 418
  • [49] From Activated Partial Thromboplastin Time to Antifactor Xa and Back AgainThe Evolution of Monitoring Unfractionated Heparin
    May, Jori E.
    Siniard, Rance Chad
    Taylor, Laura J.
    Marques, Marisa B.
    Gangaraju, Radhika
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2022, 157 (03) : 321 - 327
  • [50] Activated Partial Thromboplastin Time and Anti-Xa Measurements in Heparin Monitoring: Biochemical Basis for Discordance
    Takemoto, Clifford M.
    Streiff, Michael B.
    Shermock, Kenneth M.
    Kraus, Peggy S.
    Chen, Junnan
    Jani, Jayesh
    Kickler, Thomas
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 139 (04) : 450 - 456
12345